DEVELOPMENT OF ALLELE-SPECIFIC PCR (AS-PCR) ASSAYS TO INVESTIGATE MAJOR HIV RESISTANCE MUTATIONS TO NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTIS) AND NON NUCLEOSIDE RT INHIBITORS (NNRTI).

被引：0

作者：

Formicola, R. ^{[1
]}

Bestetti, A. ^{[1
]}

Soria, A. ^{[1
]}

Galli, L. ^{[1
]}

Danise, A. ^{[1
]}

Sala, S. ^{[1
]}

Sampaolo, M. ^{[2
]}

Galli, A. ^{[1
]}

Gianotti, N. ^{[1
]}

Clementi, M. ^{[2
]}

Lazzarin, A. ^{[1
]}

Castagna, A. ^{[1
]}

Cinque, Paola ^{[1
]}

机构：

[1] Univ Milan, Osped San Raffaele, Dipartimento Malattie Infett, I-20127 Milan, Italy

[2] Laboraf Osped San Raffaele, Milan, Italy

来源：

INFECTION | 2009年 / 37卷

关键词：

D O I：

暂无

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：44 / 44

页数：1

共 50 条

[41] Structure of HIV-2 reverse transcriptase at 2.35-Å resolution and the mechanism of resistance to non-nucleoside inhibitors
Ren, J
Bird, LE
Chamberlain, PP
Stewart-Jones, GB
Stuart, DI
Stammers, DK
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (22) : 14410 - 14415
[42] Resistance levels to non-nucleoside reverse transcriptase inhibitors among pregnant women with recent HIV infection in Malawi
Bello, George
Kagoli, Matthew
Chipeta, Sikhona
Auld, Andrew
Chang, Joy C-W
DeVos, Joshua R.
Kim, Evelyn
Mkungudza, Jonathan
Payne, Danielle
Eliya, Michael
Nyirenda, Rose
Jahn, Andreas
Mzumara, Taziona
Mvula, Bernard
Dadabhai, Sufia
Namakhoma, Ireen
Babaye, Yusuf
Giron, Amalia
Jordan, Michael R.
Bertagnolio, Silvia
O'Malley, Gabrielle
Wadonda-Kabondo, Nellie
ANTIVIRAL THERAPY, 2022, 27 (04)
[43] Pyrrolobenzothiazepinones and pyrrolobenzoxazepinones: Novel and specific non-nucleoside HIV-1 reverse transcriptase inhibitors with antiviral activity
Campiani, G
Nacci, V
Fiorini, I
DeFilippis, MP
Garofalo, A
Greco, G
Novellino, E
Altamura, S
DiRenzo, L
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (14) : 2672 - 2680
[44] HIV-1 Resistance to First- and Second-Generation Non-nucleoside Reverse Transcriptase Inhibitors
Ghosn, Jade
Chaix, Marie-Laure
Delaugerre, Constance
AIDS REVIEWS, 2009, 11 (03) : 165 - 173
[45] Structure activity relationship (SAR) studies of NNRTI (non-nucleoside reverse transcriptase inhibitors) and nucleotide reverse transcriptase (NRTI) used to combat HIV, using Gaussian computational techniques
Narayan, Saraswathi
Burgan, Destinie
Baldwin, Karleigh
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
[46] The Development of HEPT-Type HIV Non-Nucleoside Reverse Transcriptase Inhibitors and Its Implications for DABO Family
Chen, Wenmin
Zhan, Peng
Wu, Jingde
Li, Zhenyu
Liu, Xinyong
CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (27) : 4165 - 4186
[47] Antiviral profile of BILR 355 BS against a large panel of clinical isolates with mutations conferring resistance to currently available non-nucleoside reverse transcriptase inhibitors (NNRTI)
Bonneau, PR
Robinson, PA
Lie, Y
Parkin, N
van Leeuwen, R
Bethell, R
ANTIVIRAL THERAPY, 2005, 10 (04) : S81 - S81
[48] Antiviral profile of BILR 355 BS against a large panel of clinical isolates with mutations conferring resistance to currently available non-nucleoside reverse transcriptase inhibitors (NNRTI)
Bonneau, PR
Robinson, PA
Lie, Y
Parkin, N
van Leeuwen, R
Bethell, R
ANTIVIRAL THERAPY, 2005, 10 : S81 - S81
[49] Prevalence of etravirine (TMC-125) resistance mutations in HIV-infected patients with prior experience of non-nucleoside reverse transcriptase inhibitors
Poveda, Eva
Garrido, Carolina
de Mendoza, Carmen
Corral, Angelica
Cobo, Julio
Gonzalez-Lahoz, Juan
Soriano, Vincent
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (06) : 1409 - 1410
[50] Application of Structure-based Methods to Analyze Resistance Mutations for Chemically Diverse Non-Nucleoside Reverse Transcriptase Inhibitors
Tabassum, Tasnim
Azeem, Syeda M.
Muwonge, Alecia N.
Frey, Kathleen M.
CURRENT HIV RESEARCH, 2020, 18 (04) : 283 - 291

← 1 2 3 4 5 →